RecruitingNCT07303725
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
Sponsor
Palo Alto Veterans Institute for Research
Enrollment
30 participants
Start Date
Feb 1, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This is a pilot study to evaluate the feasibility, image quality, and procedural utility of a novel spectral CT technique using Canon Medical's 4D CT system during image-guided interventional oncology procedures
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is testing a new type of CT scanner called spectral CT, used during cancer procedures like embolization (blocking blood supply to tumors) and ablation (destroying tumors with heat or cold). Researchers want to see if spectral CT gives doctors better, real-time information during these procedures to improve their precision and results.
**You may be eligible if...**
- You are 18 or older
- You have a tumor that needs to be treated with embolization or ablation
- The area being treated has not been operated on or ablated before
- Your tumor is at least 1.5 cm in size
**You may NOT be eligible if...**
- You are not medically eligible for the procedure
- Your BMI is above 35 (due to imaging limitations)
- You have had prior surgery on the area being treated
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07303725
Related Trials
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
NCT000268841 location
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
NCT011093945 locations
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
NCT0722741549 locations
Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus
NCT059694963 locations
Kidney Cancer DNA Registry
NCT020878527 locations